Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Sandu Pharmaceuticals: Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026.
News Announcement

Sandu Pharmaceuticals: Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026.

03-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Sandu Pharma

Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June 2026. 2.To consider any other matter with the permission of the Chair

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan